GITNUX MARKETDATA REPORT 2024

Ozempic Industry Statistics

Ozempic is a leading drug in the diabetes treatment industry with significant market growth and high revenue potential.

Last Updated: June 23, 2024

How we write

In this post, we will explore key statistics surrounding the Ozempic industry, shedding light on its impact on diabetes treatment, market trends, prescription rates, financial performance, and more. From its efficacy in reducing HbA1c levels to its global market projections, the data presented will provide valuable insights into the world of Ozempic and its significance within the healthcare landscape.

Statistic 1

"Ozempic can lower HbA1c levels by up to 1.5% over a year."

Statistic 2

"Annual sales of Ozempic reached $3.7 billion in 2021."

Statistic 3

"Approximately 1.2 million prescriptions for Ozempic were filled in the United States in 2021."

Statistic 4

"The European Medicines Agency (EMA) approved Ozempic for use in 2018."

Statistic 5

"Ozempic use has been associated with a 14% reduction in major cardiovascular events."

Statistic 6

"In Japan, Ozempic captured 18% of the GLP-1 receptor agonist market in 2020."

Statistic 7

"Ozempic was the 10th most prescribed diabetes medication in the U.S. in 2021."

Statistic 8

"The cost of Ozempic increased by 5% from 2020 to 2021."

Statistic 9

"The proportion of patients achieving an HbA1c target of <7% with Ozempic was 68% in clinical trials."

Statistic 10

"Ozempic has been shown to reduce the risk of kidney complications in diabetic patients by 22%."

Statistic 11

"Ozempic accounted for 25% of Novo Nordisk’s total revenue in 2021."

Statistic 12

"Novo Nordisk, the manufacturer of Ozempic, reported a 32% increase in sales of Ozempic in the first quarter of 2022."

Statistic 13

"Ozempic was approved by the FDA for diabetes treatment in December 2017."

Statistic 14

"Clinical trials demonstrated that Ozempic could lead to an average weight loss of 4.5 kg within a year."

Statistic 15

"The average monthly cost of Ozempic for patients without insurance is approximately $800."

Statistic 16

"Over 60% of people taking Ozempic experience significant weight loss."

Statistic 17

"Side effects such as nausea and vomiting occur in about 20% of Ozempic users."

Statistic 18

"Ozempic is available in over 50 countries worldwide."

Statistic 19

"Ozempic is most commonly prescribed by endocrinologists and primary care physicians."

Statistic 20

"The global market for Ozempic is projected to grow at a compound annual growth rate (CAGR) of 8.1% from 2021 to 2026."

Ozempic has made significant strides in the diabetes medication industry, with impressive statistics showcasing its efficacy and market success. From its ability to lower HbA1c levels by up to 1.5% over a year to capturing a substantial share of the market in different regions, Ozempic has proven to be a valuable treatment option. The approval of Ozempic by regulatory bodies, its impact on cardiovascular health and kidney complications, and its contribution to Novo Nordisk’s revenue highlight its significance in the healthcare landscape. As the global market for Ozempic continues to expand, it is evident that this medication plays a crucial role in diabetes management and is poised for continued growth in the coming years.

Jannik Lindner

Jannik is the Co-Founder of Gitnux and has been working in the digital space since 2016. He is specialized in content and tech.

Can You Trust Our Report?

The statistics are checked by us and then entered into the database. Our market data reports have been linked to by some of the largest publishers and companies on the Internet.

Learn more about our process here.